Home LiteratureArticle Details
PMID: 1977515 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Cancer research ·Vol. 50 ·No. 22 ·1990-11-15 ·Pages 7184-9

Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y

Abstract

Allele loss on a specific chromosome has implied the existence of a tumor suppressor gene such as the p53 gene and the RB gene. In order to determine which chromosome(s) carries a tumor suppressor gene(s) that contributes to tumor progression in primary breast cancer, we analyzed the loss of heterozygosity for each autosomal chromosome arm by using 39 restriction fragment length polymorphism markers including 25 variable numbers of tandem repeat probes. In 79 primary breast cancers, we found the frequent loss on the long arm of chromosome 13 (21%), the long arm of chromosome 16 (45%), and the short arm of chromosome 17 (56%). Interestingly, breast cancers in which loss of both chromosomes 13q and 17p was detected showed more malignant histopathological features, and a group of the tumors in which chromosome 16q loss was detected presented with frequent lymph node metastasis. Furthermore, the result of the deletion mapping on chromosome 17p implied the existence of a tumor suppressor gene distal to the p53 gene as well as the p53 gene itself for primary breast cancer. These results suggest that at least 4 tumor suppressor genes exist on chromosomes 13q, 16q, and 17p for primary breast cancer.

MeSH Terms
Blotting, Southern Breast Neoplasms/genetics Chromosome Mapping Chromosomes, Human, Pair 16 Chromosomes, Human, Pair 17 DNA Probes Fibroblast Growth Factor 3 Fibroblast Growth Factors Heterozygote Humans Lymphatic Metastasis Oncogenes/genetics Polymorphism, Restriction Fragment Length Proto-Oncogene Proteins/genetics Receptor, ErbB-2
Chemicals
DNA Probes FGF3 protein, human Fibroblast Growth Factor 3 Proto-Oncogene Proteins Fibroblast Growth Factors Receptor, ErbB-2
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Sato T
Department of Biochemistry, Cancer Institute, Tokyo, Japan.
Tanigami A
Yamakawa K
Akiyama F
Kasumi F
Sakamoto G
Nakamura Y
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1990-11-15
Pages
7184-9
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]